Roeren T, Tonn W, Richter G M, Brambs H J, Kauffmann G
Abteilung Radiodiagnostik der Universitätsklinik Heidelberg.
Rofo. 1996 Aug;165(2):181-7. doi: 10.1055/s-2007-1015736.
To evaluate the clinical efficiency of percutaneously placed metallic stents in patients with malignant biliary obstruction.
In a prospective study 92 consecutive patients with malignant biliary obstruction were treated percutaneously with expandable metallic stents. Technical and clinical parameters during the procedure and regular follow-up were evaluated.
Technical and clinical success rates were 100 and 91% respectively. During stent implantation we observed no severe complications. 30-day morbidity and mortality were 12 and 13% respectively. Late complications occurred in 35%, in 20.7% due to reocclusion of the bile ducts which was treated successfully in 17/19 patients. 75% of patients benefited from the procedure. Primary and secondary patency were 79.3 and 97.8%, respectively.
Percutaneous transhepatic implantation of expandable metallic stents is a reliable and safe therapy for malignant jaundice and has a definite positive impact on the patients quality of life.
评估经皮置入金属支架治疗恶性胆道梗阻患者的临床疗效。
在一项前瞻性研究中，对92例连续性恶性胆道梗阻患者行经皮可扩张金属支架置入治疗。评估手术过程中的技术和临床参数以及定期随访情况。
技术成功率和临床成功率分别为100%和91%。支架置入过程中未观察到严重并发症。30天发病率和死亡率分别为12%和13%。晚期并发症发生率为35%，其中20.7%是由于胆管再闭塞，19例患者中有17例成功治疗。75%的患者从该治疗中获益。一期通畅率和二期通畅率分别为79.3%和97.8%。
经皮肝穿刺置入可扩张金属支架是治疗恶性黄疸的一种可靠且安全的疗法，对患者生活质量有明确的积极影响。
